Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Plans laid for trials of emergency care medicines to treat children


Sick child

In emergencies, parents’ prior consent for treatment is usually hard to obtain

Research into emergency care for children will no longer require prior authorisation if legislative amendments proposed by the Medicines and Healthcare products Regulatory Agency are adopted.

The MHRA says that the current system prevents trials of emergency-care medicines for children taking place in the UK because prior consent cannot usually be obtained.

Its proposed amendments, which have opened for consultation, suggest that, in certain emergencies, there should be an exception to the general rule that informed consent must be obtained from a child’s parent or legal representative before participation in trials of medicines.

An ethics committee would have to approve the detailed circumstances in which the exception would be used and consent would have to be obtained as soon as reasonably practicable after participation starts. The MHRA envisages that, in practice, the change would mirror an amendment made last year in relation to incapacitated adults.

The change is one of three suggested changes to the Medicines for Human Use (Clinical Trials) Regulations 2004. The other two relate to delegating some of the Gene Therapy Advisory Committee’s functions and amending the regulations for appointing members to UK ethics committees. The proposals are available online.

The deadline for comments is 7 December 2007.

Citation: The Pharmaceutical Journal URI: 10004848

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • International Research in Healthcare

    International Research in Healthcare

    Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.

    £38.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Injectable Drugs Guide

    Injectable Drugs Guide

    A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.

    £54.00Buy now
  • Good Pharmacovigilance Practice Guide

    Good Pharmacovigilance Practice Guide

    An essential guide on pharmacovigilance of medicinal products for human use. Practical advice for developing effective pharmacovigilance systems.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.